VIMPAT 150 mg, film-coated tablets 56 tablets, CIP 3400938830170
Active ingredients: Lacosamide
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tablets, CIP 3400938830170orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VIMPAT 150 mg, comprimés pelliculés
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 56 comprimé(s)
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Oct 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62229123CIP73883017CIP133400938830170Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LACOSAMIDEcomprimé | 150 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.